Celyad Oncology S.A. (CYAD) Stock Analysis

DELISTED 2023

What happened to Celyad Oncology S.A. (CYAD) stock?

Celyad Oncology S.A. (CYAD) no longer trades on public markets. It was delisted in May 2023. The figures below are historical and are not a current quote.

Status:: Delisted — no longer trades
Delisting date:: May 2023
Last recorded price (historical):: $0.47 (last quote on record before the May 2023 delisting; historical, not a current quote)

MCap: $14.2M| P/E Ratio: 13.38| Vol: 49.0K| 52-wk range: $0.15 – $3.07

P/E 13.38 means the share price is 13.38 times one year of earnings per share. Market cap $14.2M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Celyad Oncology S.A. (CYAD). Celyad Oncology S.A. is a clinical-stage biopharmaceutical company based in Belgium, specializing in the discovery and development of CAR-T cell therapies for various cancers.

Last analyzed: Jun 15, 2026

Celyad Oncology S.A. is a clinical-stage biopharmaceutical company based in Belgium, specializing in the discovery and development of CAR-T cell therapies for various cancers. Its pipeline includes both allogeneic and autologous CAR-T candidates targeting metastatic colorectal cancer, multiple myeloma, acute myeloid leukemia, and myelodysplastic syndromes.

Dated analysis: the newest financial statements on file are 28 months old (Jun 1, 2024), so the figures and score below describe that period, not today.

Celyad Oncology S.A. (CYAD) Healthcare & Pipeline Overview

Employees35

IndustryBiotechnology

SectorHealthcare

Model self-rating on this text: 79% (not a measure of the evidence) Updated: Jun 15, 2026

Celyad Oncology S.A. ADR Information Sponsored

Celyad Oncology S.A. (CYAD) trades in the U.S. as an American Depositary Receipt (ADR).

ADR Level: 2
ADR Ratio: 1:1

More about this archive record

Can I still buy CYAD shares?

No. CYAD stopped trading on public markets in May 2023, so the shares are not available through a broker. Anything you see quoted for CYAD elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CYAD stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Celyad Oncology S.A.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated Jun 15, 2026

Data Sources & Methodology

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: Jun 15, 2026.

Data provided for informational purposes only.